CSL Limited (OTCMKTS:CSLLY) Short Interest Up 151.1% in January

CSL Limited (OTCMKTS:CSLLY) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 31st total of 4,700 shares. Based on an average trading volume of 159,800 shares, the days-to-cover ratio is currently 0.1 days.

CSL Stock Up 1.1 %

CSLLY stock traded up $0.94 during trading on Thursday, hitting $87.17. The company had a trading volume of 63,438 shares, compared to its average volume of 87,568. CSL has a 52-week low of $83.31 and a 52-week high of $109.00. The company has a 50 day simple moving average of $88.20 and a 200-day simple moving average of $95.52. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group raised shares of CSL to a “strong-buy” rating in a research note on Thursday, January 16th.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.